Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Exact Sciences (NASDAQ:EXAS) in the last three months.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $79.86, with a high estimate of $95.00 and a low estimate of $67.00. Experiencing a 1.81% decline, the current average is now lower than the previous average price target of $81.33.

Understanding Analyst Ratings: A Comprehensive Breakdown

The standing of Exact Sciences among...